Transition metal chalcogenides (TMX) have attracted energy researchers due to their role as high-performance electrode materials for energy storage devices. A facile one-pot hydrothermal technique was adopted to synthesize a molybdenum disulfide/cadmium sulfide (MoS/CdS) (MCS) composite. The as-prepared samples were subjected to characterization techniques such as XRD, FT-IR, SEM, TEM, and XPS to assess their structure, morphology, and oxidation states. The MoS/CdS (MCS) composites were prepared in three different ratios of molybdenum and cadmium metals. Among them, the MCS 1:2 (Mo:Cd) ratio showed better electrochemical performance with a high specific capacitance of 1336 F g (high specific capacity of 185.83 mAh g) at a specific current of 1 A g for half-cell studies. Later, a hybrid supercapacitor (HSC) device was fabricated with N-doped graphene (NG) as an anode and MCS (1:2) as a cathode, delivering a high specific energy of 34 Wh kg and a specific power of 7500 W kg. The high nitrogen content in the MoS structure in MCS composites alters the device's performance, where CdS supports the composite structure through its conductivity and encourages the easy accessibility of ions. The device withstands up to 10 000 cycles with a higher Coulombic efficiency of 97% and a capacitance retention of 90.25%. The high-performance NG//MCS (1:2) HSC may be a potential candidate alternative to the existing conventional material.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsami.4c07361 | DOI Listing |
Diagn Progn Res
January 2025
Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham, UK.
Background: Pressure injuries (PIs) place a substantial burden on healthcare systems worldwide. Risk stratification of those who are at risk of developing PIs allows preventive interventions to be focused on patients who are at the highest risk. The considerable number of risk assessment scales and prediction models available underscores the need for a thorough evaluation of their development, validation, and clinical utility.
View Article and Find Full Text PDFBMC Chem
January 2025
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, University of Alexandria, Elmessalah, Alexandria, 21521, Egypt.
A simple, rapid, and reproducible high-performance liquid chromatography (HPLC) method has been developed and validated for the determination of β-sitosterol in the pharmaceutical dosage form of moist exposed burn ointment (MEBO). This method involved an effective sample procedure for extraction of β-sitosterol from MEBO using an alkali saponification agent composed of 0.8 N ethanolic NaOH and diethyl ether.
View Article and Find Full Text PDFMol Cancer
January 2025
Department of Medicine, Section of Epidemiology and Population Sciences, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Lipid nanoparticles (LNPs) for mRNA delivery have advanced significantly, but LNP-mediated DNA delivery still faces clinical challenges. This study compared various LNP formulations for delivering DNA-encoded biologics, assessing their expression efficacy and the protective immunity generated by LNP-encapsulated DNA in different models. The LNP formulation used in Moderna's Spikevax mRNA vaccine (LNP-M) demonstrated a stable nanoparticle structure, high expression efficiency, and low toxicity.
View Article and Find Full Text PDFJ Transl Med
January 2025
Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, No. 569 Xinsi Road, Xi'an, China.
Autophagy is responsible for maintaining cellular balance and ensuring survival. Autophagy plays a crucial role in the development of diseases, particularly human cancers, with actions that can either promote survival or induce cell death. However, brain tumors contribute to high levels of both mortality and morbidity globally, with resistance to treatments being acquired due to genetic mutations and dysregulation of molecular mechanisms, among other factors.
View Article and Find Full Text PDFMol Cancer
January 2025
Department of Neurosurgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, 570208, China.
This review highlights recent progress in exosome-based drug delivery for cancer therapy, covering exosome biogenesis, cargo selection mechanisms, and their application across multiple cancer types. As small extracellular vesicles, exosomes exhibit high biocompatibility and low immunogenicity, making them ideal drug delivery vehicles capable of efficiently targeting cancer cells, minimizing off-target damage and side effects. This review aims to explore the potential of exosomes in cancer therapy, with a focus on applications in chemotherapy, gene therapy, and immunomodulation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!